While more mechanism-based studies are needed, it was reported that monensin can reduce the expression of cyclin A, CDK6, and cyclin D1while inducing programmed cell death-related genes, such as caspase-3, caspase-8, Bax, and mitochondria transmembrane potential in some types of human cancer lines76–80. The gene discussed is CASP3; the disease is cancer.